Cargando…

Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?

This case report presents the case of a 29 weeks pregnant woman in her late twenties who was seen at the emergency department of a hospital with a seizure of unknown cause. By anamnesis and hetero-anamnesis the use of illicit gamma-hydroxybutyric acid (GHB) was revealed. Examination showed dilated p...

Descripción completa

Detalles Bibliográficos
Autores principales: van Mechelen, JC, Dijkstra, BAG, Vergouwen, ACM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001713/
https://www.ncbi.nlm.nih.gov/pubmed/31796453
http://dx.doi.org/10.1136/bcr-2019-230997
_version_ 1783494288602038272
author van Mechelen, JC
Dijkstra, BAG
Vergouwen, ACM
author_facet van Mechelen, JC
Dijkstra, BAG
Vergouwen, ACM
author_sort van Mechelen, JC
collection PubMed
description This case report presents the case of a 29 weeks pregnant woman in her late twenties who was seen at the emergency department of a hospital with a seizure of unknown cause. By anamnesis and hetero-anamnesis the use of illicit gamma-hydroxybutyric acid (GHB) was revealed. Examination showed dilated pupils, sweating, tremor, tachycardia and bradyphrenic thinking. Subsequently, the seizure was indicated as a severe illicit GHB withdrawal symptom. Thereafter, treatment had to be decided on in the absence of evidence-based and practiced-based guidelines and treatment options for this specific patient population. Initially diazepam was started, which was later on substituted by sodium oxybate. Despite the critical professional situation the patient gave birth to a healthy daughter after 37 weeks of pregnancy.
format Online
Article
Text
id pubmed-7001713
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70017132020-02-19 Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do? van Mechelen, JC Dijkstra, BAG Vergouwen, ACM BMJ Case Rep Reminder of Important Clinical Lesson This case report presents the case of a 29 weeks pregnant woman in her late twenties who was seen at the emergency department of a hospital with a seizure of unknown cause. By anamnesis and hetero-anamnesis the use of illicit gamma-hydroxybutyric acid (GHB) was revealed. Examination showed dilated pupils, sweating, tremor, tachycardia and bradyphrenic thinking. Subsequently, the seizure was indicated as a severe illicit GHB withdrawal symptom. Thereafter, treatment had to be decided on in the absence of evidence-based and practiced-based guidelines and treatment options for this specific patient population. Initially diazepam was started, which was later on substituted by sodium oxybate. Despite the critical professional situation the patient gave birth to a healthy daughter after 37 weeks of pregnancy. BMJ Publishing Group 2019-11-29 /pmc/articles/PMC7001713/ /pubmed/31796453 http://dx.doi.org/10.1136/bcr-2019-230997 Text en © BMJ Publishing Group Limited 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Reminder of Important Clinical Lesson
van Mechelen, JC
Dijkstra, BAG
Vergouwen, ACM
Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?
title Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?
title_full Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?
title_fullStr Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?
title_full_unstemmed Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?
title_short Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?
title_sort severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?
topic Reminder of Important Clinical Lesson
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001713/
https://www.ncbi.nlm.nih.gov/pubmed/31796453
http://dx.doi.org/10.1136/bcr-2019-230997
work_keys_str_mv AT vanmechelenjc severeillicitgammahydroxybutyricacidwithdrawalinapregnantwomanwhattodo
AT dijkstrabag severeillicitgammahydroxybutyricacidwithdrawalinapregnantwomanwhattodo
AT vergouwenacm severeillicitgammahydroxybutyricacidwithdrawalinapregnantwomanwhattodo